caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1538329776

Branden RhodesD.P.M.

PodiatryBaltimore, MDI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Branden Rhodes's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 16 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MERCY MEDICAL CENTER INC78323
Quest Diagnostics Incorporated Md
Clinical Laboratory · Baltimore, MD
3675
Kak Kim
Vascular Surgery · Flushing, NY
29130
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2851
Bakotic Pathology Associates, Llc
Clinical Laboratory · Alpharetta, GA
2477
NPI 12553860412381
DOYLE, TIMOTHY2151
Fernando Ferro
Internal Medicine · Baltimore, MD
2045
FRANKLIN SQUARE HOSPITAL CENTER, INC1841
Ankur Gupta
Diagnostic Radiology · New York, NY
1746
Michael Zang
Internal Medicine · Catonsville, MD
1640
Shawn Peffall
Dermatology · Baltimore, MD
1536
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,438
Unique beneficiaries
—
Total services
2,503
Distinct HCPCS
15
Medicare payment
$142K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 343 Podiatry providers in MD — above median (cohort median 2,072).
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
575
Beneficiaries
—
Total drug cost
$30K
Distinct drugs
14
Brand share
7.1%
Top prescribed drugs
Gabapentin92 claims
Ketoconazole90 claims
Ciclopirox83 claims
Ammonium Lactate70 claims
Terbinafine Hcl37 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$284
Payment records
7
By payment type
Food and Beverage$284